ReviewCureus2025
Prognostic Value of C-reactive Protein and Neutrophil-to-Lymphocyte Ratio in Predicting Postoperative Infections After Gastrointestinal Surgery: A Meta-Analysis.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Explainable Machine Learning Predictive Models for Surgical Site Infections: Scoping Review.Journal of medical Internet research · 2026Article
- An inflammation-nutrition composite index and its dynamic change for predicting postoperative wound complications.Langenbeck's archives of surgery · 2026Observational
- The Systemic Immune-Inflammation Index and High-Sensitivity C-Reactive Protein to High-Density Lipoprotein Cholesterol Ratio Predict Moderate and Severe Coronary Artery Stenosis in Older Patients with Coronary Heart Disease.Clinical interventions in aging · 2026Article
- Development and validation of a SHAP-interpretable GBM model for predicting postoperative recurrence of anal Fistula.Frontiers in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postoperative infectious complications remain a significant cause of morbidity following gastrointestinal (GI) surgeries, necessitating early and reliable prognostic markers to guide timely intervention. This meta-analysis aimed to evaluate the predictive value of two widely available inflammatory biomarkers, C-reactive protein (CRP) and neutrophil-to-lymphocyte ratio (NLR), in forecasting postoperative infections in patients undergoing GI surgery. A systematic search of databases and trial registries was conducted, and eight studies meeting the inclusion criteria were analyzed. A total of 2,020 patients were included across these studies, covering various GI surgical procedures such as gastric resection, bile duct repair, appendectomy, and Crohn's disease surgery. The meta-analysis revealed that elevated NLR was significantly associated with an increased risk of postoperative infections, with a pooled odds ratio (OR) of 2.54 (95% CI: 1.84-3.52, p < 0.00001) and moderate heterogeneity (I² = 38.6%). Likewise, CRP and the CRP-to-albumin ratio (CAR) also demonstrated strong predictive value, with a pooled OR of 2.43 (95% CI: 1.45-4.09, p = 0.0007) and low heterogeneity (I² = 22.4%). These findings are in line with prior research that supports the role of systemic inflammatory markers in perioperative risk assessment. The use of NLR and CRP-based markers offers a simple, cost-effective, and accessible approach for early identification of patients at high risk for infectious complications. This can help clinicians initiate preventive strategies and optimize postoperative care. While further large-scale, prospective studies are needed to standardize cutoff values and timing of assessment, our results support incorporating NLR and CRP into routine perioperative evaluation in GI surgical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.